Your browser doesn't support javascript.
loading
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Wakabayashi, Hiroshi; Kayano, Daiki; Inaki, Anri; Araki, Raita; Kuroda, Rie; Ikawa, Yasuhiro; Fujiki, Toshihiro; Akatani, Norihito; Yamase, Takafumi; Watanabe, Satoru; Hiromasa, Tomo; Kunita, Yuji; Mori, Hiroshi; Saito, Shintaro; Nishimura, Ryosei; Wada, Taizo; Kinuya, Seigo.
Afiliação
  • Wakabayashi H; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan. wakabayashi@staff.kanazawa-u.ac.jp.
  • Kayano D; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Inaki A; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Araki R; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Kuroda R; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Ikawa Y; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Fujiki T; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Akatani N; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Yamase T; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Watanabe S; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Hiromasa T; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Kunita Y; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Mori H; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Saito S; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Nishimura R; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Wada T; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
  • Kinuya S; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Ann Nucl Med ; 34(11): 840-846, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32862362

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doses de Radiação / Ganglioneuroblastoma / Quimioterapia de Consolidação / Neuroblastoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Ann Nucl Med Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doses de Radiação / Ganglioneuroblastoma / Quimioterapia de Consolidação / Neuroblastoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Ann Nucl Med Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão